Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nahoko Fujimoto"'
Autor:
Nahoko Fujimoto, Katsuya Nagaoka, Ichiro Tatsuno, Hisashi Oishi, Makoto Tomita, Tadao Hasegawa, Yasuhito Tanaka, Takahiro Matsumoto
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Ultraviolet (UV) irradiation offers an effective and convenient method for the disinfection of pathogenic microorganisms. However, UV irradiation causes protein and/or DNA damage; therefore, further insight into the performance of different
Externí odkaz:
https://doaj.org/article/9a26ff5864944881bd4da5f6dac59583
Autor:
Satoshi Narahara, Takehisa Watanabe, Katsuya Nagaoka, Nahoko Fujimoto, Yoki Furuta, Kentaro Tanaka, Takayuki Tokunaga, Takeshi Kawasaki, Yoko Yoshimaru, Hiroko Setoyama, Kentaro Oniki, Junji Saruwatari, Masakuni Tateyama, Hideaki Naoe, Motohiko Tanaka, Yasuhito Tanaka, Yutaka Sasaki
Publikováno v:
Hepatology Communications, Vol 6, Iss 5, Pp 1198-1212 (2022)
Advanced hepatocellular carcinoma (HCC) remains a highly lethal malignancy, although several systemic therapeutic options are available, including sorafenib (SFN), which has been one of the standard treatment agents for almost a decade. As early pred
Externí odkaz:
https://doaj.org/article/45aa45a8d48f45b7b7adf065cdba44de
Autor:
Yoki Furuta, Ryosuke Gushima, Hideaki Naoe, Munenori Honda, Yuiko Tsuruta, Katsuya Nagaoka, Takehisa Watanabe, Masakuni Tateyama, Nahoko Fujimoto, Shinya Hirata, Eiko Miyagawa, Komei Sakata, Yumiko Mizuhashi, Mikako Iwakura, Masayuki Murai, Masao Matsuoka, Yoshihiro Komohara, Yasuhito Tanaka
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 9, p 3131 (2023)
Background: Mediterranean fever (MEFV) gene mutations are responsible for familial Mediterranean fever (FMF) and associated with other inflammatory diseases. However, the effects of MEFV gene mutations on intestinal Behçet’s disease (BD) are unkno
Externí odkaz:
https://doaj.org/article/4f15a08ffa4944719508883b0a139176
Autor:
Masakuni Tateyama, Hiroko Setoyama, Yoki Furuta, Kentaro Tanaka, Junji Saruwatari, Satoshi Narahara, Yasuhito Tanaka, Takehisa Watanabe, Nahoko Fujimoto, Katsuya Nagaoka, Yutaka Sasaki, Hideaki Naoe, Yoko Yoshimaru, Takayuki Tokunaga, Takeshi Kawasaki, Motohiko Tanaka, Kentaro Oniki
Publikováno v:
Hepatology communications. 6(5)
Advanced hepatocellular carcinoma (HCC) remains a highly lethal malignancy, although several systemic therapeutic options are available, including sorafenib (SFN), which has been one of the standard treatment agents for almost a decade. As early pred